Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.
Department of Veterinary Surgery, Veterinary Medicine and Biosciences, College Station, TX 77843-4475, USA.
Metallomics. 2019 Nov 1;11(11):1900-1911. doi: 10.1039/c9mt00152b. Epub 2019 Oct 11.
Nutrient iron entering the blood binds transferrin (TFN), which delivers iron to cells in the body. In healthy individuals, ∼30% of TFN is iron-bound while the remainder is unbound (apo-TFN). TFN saturates the plasma of individuals with iron-overload diseases such as hereditary hemochromatosis, prompting release of a poorly-defined low-molecular-mass (LMM) iron species called non-transferrin-bound iron (NTBI). An experiment was devised to directly detect NTBI in plasma of iron-deficient pigs and to assess the role of the liver which is known to bind NTBI. Catheters were surgically installed in the portal vein (PV) and either the caudal vena cava or the cranial vena cava. After the animals recovered, Fe II ascorbate was injected into the stomach via a feeding tube. Blood was removed through the catheters before and after injection; plasma became Fe-enriched after injection. Fe-enriched plasma was passed through a 10 kDa cutoff membrane and the flow-through solution (FTS) was subjected to size-exclusion liquid chromatography (LC). The eluent flowed into an ICP-MS where Fe and Fe were detected. Low-intensity iron peaks with masses of 400-1600 Da were observed, but none became enriched in Fe after injection. Rather, the injected Fe bound to apo-TFN. Viewed naively, this implies that nutrient-derived Fe in healthy mammals passes from the intestines to apo-TFN without first entering the blood as a LMM intermediate. In this case, nutrient iron exported from intestinal enterocytes of healthy individuals may quickly bind apo-TFN such that LMM iron species do not accumulate in blood plasma. Some Fe from the FTS may have adsorbed onto the column. In any event, the LMM iron species in plasma that eluted from the column must have originated from iron stored within the body, perhaps in macrophages - not directly from nutrient iron absorption. The liver absorbed and released LMM iron species, but the effect was modest, consistent with its role as a dynamic iron buffer. Passage through the liver also altered the distribution of different forms of TFN present in the PV.
进入血液的营养铁与转铁蛋白(TFN)结合,TFN 将铁输送到体内的细胞中。在健康个体中,约 30%的 TFN 与铁结合,其余部分未结合(apo-TFN)。TFN 使铁超负荷疾病(如遗传性血色素沉着症)患者的血浆饱和,促使释放一种定义不明确的低分子质量(LMM)铁物质,称为非转铁蛋白结合铁(NTBI)。设计了一项实验来直接检测缺铁猪血浆中的 NTBI,并评估肝脏的作用,已知肝脏会结合 NTBI。通过手术将导管插入门静脉(PV)中,然后插入尾腔静脉或颅腔静脉。动物恢复后,通过喂养管将 Fe II 抗坏血酸注入胃中。注射前后通过导管抽取血液;注射后血浆中 Fe 含量增加。将富含 Fe 的血浆通过 10 kDa 截止膜,将滤液(FTS)进行大小排阻液相色谱(LC)。洗脱液流入 ICP-MS 中,检测 Fe 和 Fe。观察到质量为 400-1600 Da 的低强度铁峰,但没有一种在注射后变得富集。相反,注射的 Fe 与 apo-TFN 结合。从表面上看,这意味着健康哺乳动物的营养铁从肠道传递到 apo-TFN,而无需首先作为 LMM 中间体进入血液。在这种情况下,健康个体肠上皮细胞输出的营养铁可能会迅速与 apo-TFN 结合,从而使 LMM 铁物质不会在血浆中积累。FTS 中的一些 Fe 可能已吸附到柱子上。无论如何,从柱子上洗脱的血浆中的 LMM 铁物质必须来自体内储存的铁,可能来自巨噬细胞 - 而不是直接来自营养铁吸收。肝脏吸收并释放 LMM 铁物质,但效果适中,与其作为动态铁缓冲剂的作用一致。穿过肝脏也改变了存在于 PV 中的不同形式的 TFN 的分布。